LYV vs RAPP · P/E 49, rev $11.46B vs rev $20.0M
Live Nation Entertainment Inc (LYV) versus Rapport Therapeutics, Inc. Common Stock (RAPP) — a side-by-side from cached financials, not a winner call.
Live Nation Entertainment Inc (LYV) is a entertainment company listed on US.
Rapport Therapeutics, Inc. Common Stock (RAPP) is a biotechnology company listed on US.
Latest reported LYV revenue for 2026-06-30 was $11.46B. Net income was -$94.7M. LYV currently screens at market cap $33.36B and trailing P/E 48.8.
Latest reported RAPP revenue for 2026-06-30 was $20.0M. Net income was -$76.5M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. RAPP currently screens at market cap $532.9M.
LYV currently screens at market cap $33.36B and trailing P/E 48.8. RAPP currently screens at market cap $532.9M.
Not investment advice. Open the LYV and RAPP stock pages for the full models.
Not investment advice.